Transient Global Amnesia Summary

56 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: A syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. (From Adams et al., Principles of Neurology, 6th ed, pp429-30)

Also Known As: Amnesia, Transient Global; TGA (Transient Global Amnesia); Global Amnesia, Transient; TGAs (Transient Global Amnesia)

Key Drugs and Agents for Transient Global Amnesia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:

Brain-Derived Neurotrophic Factor (BDNF) : 1 study in 1 result : IBA
Benzodiazepines : 3 results : IBA
sildenafil (Viagra) : 3 results : FDA 4
Technetium Tc 99m Exametazime (Ceretec) : 2 results : FDA 1
Antiphospholipid Antibodies : 2 results : IBA
Xenon : 2 results : IBA
Tea : 2 results : IBA
Oxygen : 2 results : IBA
Iopamidol (Isovue) : 2 results : FDA 11 Generic
Iohexol (Omnipaque) : 2 results : FDA 2

Show All >>

Diseases Related to Transient Global Amnesia

Show All >>

Key Therapies for Transient Global Amnesia

Efficacy Chart >>